- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Face-to-face consultations
Last updated: 29 Jun 2020
- Home chemotherapy
I have, graduated from Aristotle University Medical School, Thessalonika, Greece in 1997. Following my graduation with ‘suma cum laude’, I have spent 18 months as a GP registrar on the national Greek mandatory medical rotation in a village in Greece providing GP equivalent medical cover to a population of 2000 people. This was followed by 3 years of General Medical Training in Greece where my interest in Haematology began. As I feel that clinical medicine is strongly related to research I was committed into research from my early days in Medicine and following my General Medical Training I was successfully granted my PhD title in June 2002. I was trained as a Specialist Registrar in Haematology in the West Midlands region and completed my training at the end of March 2011.I was appointed as a Consultant Haematologist at Birmingham Heartlands Hospital on the 1st of April 2011 and during my Consultant job I have developed a specialist interest in malignant haematology and stem cell transplantation while I have published my clinical research in peer review journals.I am also a member of the national working party for AML and the intrathecal chemotherapy lead for Heart of England NHS Trust. I always try to keep myself up to date with the recent advances in haematology and regularly attend National and International conferences where I present my scientific work too. Currently I am the Deputy Divisional Director for University Hospital Birmingham Division 5 for Haematology and Stem cell transplantation at Heart of england NHS Trust Haematology Department. I have also successfully finished my MBA health management studies at Keele University in September 2014
I have managed to build excellent relationships with patients, colleagues and staff throughout my career which is reflected in the official feedback I received during my NHS appraisals. I am very approachable and eager to provide the best possible care to my patients. I am very enthusiastic with teaching trainees in Haematology being the educational supervisor of the haematology SpRs at Heart of England Hospital for the last 2 years. I am very keen on sports with football, basketball and beach volleyball being my main activities outside medicine.
Areas of interest
Myeloid malignancies (Acute myeloid leukaemia, myelodysplastic syndrome);
Hodgkins and non-Hodgkin's lymphoma;
Chronic lymphocytic leukaemia (CLL);
Chronic myeloid leukaemia
Myeloproliferative disorders (Polycythaemia rubra vera,Essential thrombocythaemia,Myelofibrosis)
Current NHS consultant posts held
Programme. Director stem cell transplant Department Heart of England NHS Trust
Consultant Haematologist/Bone Marrow transplantation
Heart of england NHS Trust NHS UK
Deputy divisional director Div. 5b University Hospitals. Birmingham
PhD awarded 2002
Currently performing Clinical research in haematooncology and bone marrow transplantation published in different peer reviewed papers
MBA Health Executive Keele university 2014
Reading, Travelling, Basketball, Football, Beach voleyball
Team of the year platinum award as head of haematology Department 2019
Finalist for Outstanding Clinical care 2018
Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from the UK PNH Network.
Griffin M, Neilly I, Nikolousis M, Narayanan S, Lowndes K, Koh M, Ros J, Ingram W, Couzens S, Karim R, Morgan L, McMullin M, Sharma N, Mitchell L, Layton M, Medd P, Chattree S, Hill A.
Br J Haematol. 2017 Aug 31.
Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.
Randall K, Kaparou M, Xenou E, Paneesha S, Kishore B, Kanellopoulos A, Lovell R, Holder K, Suhr J, Baker L, Ryan L, Nikolousis E.
Eur J Haematol. 2017 Oct;99(4):300-305. doi:
Sclerosing angiomatoid nodular transformation of the spleen.Clin Case Rep. 2015 Oct;3(10):888-90. doi:
Intestinal lymphoma--a review of the management of emergency presentations to the general surgeon.
Abbott S, Nikolousis E, Badger I.
Int J Colorectal Dis. 2015 Feb;30(2):151-7.
Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study.
Bone Marrow Transplant. 2015 Jan;50(1):82-6.
Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm.Hematol Rep. 2014 Jan 29;6(1):5119.
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant.
Leuk Res. 2013 May;37(5):561-5.
Courses offered to GPs
Advances in leukaemia treatment
Role of primary practice in the treatment of Haematological patients
The clinical approach of patient with a differential diagnosis of haematological conditions
Available upon request
Patient satisfaction registered in Equinity system
- MBBS Aristotle University of Thessaloniki Greece 1997
- PhD Aristotle University of Thessaloniki Greece 2002
- MBA Health management Keele University 2014
Reference number 6044482
Details of entry to specialist register
- Haematology, 2011
Affiliations / memberships
Royal College of Physicians
Royal College of Pathologists
European Haematology Association
National AML working party
- 1 Damson Parkway SOLIHULL B91 2PP
- 17:30 - 20:30
- 07922 099653
- Spire Little Aston Hospital, B74 3UP
- 17:30 - 20:30
- 0121 424 3698
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Dr Emmanouil (Manos) Nikolousis